Meetings, Congress News, Society News, Inside ESCRS
Experience iNovation Day
Learn about the hottest topics in ophthalmology!
Building on its success at previous ESCRS Congresses in Milan and Vienna, the ESCRS iNovation® Day programme will introduce delegates to the latest technological developments in the pipeline—along with expert discussion panels on the most urgent clinical needs and barriers to success in anterior segment care. The iNovation programme takes place on Friday, 6 September, at the Fira Barcelona Gran Via, offering a rare opportunity to network with leading researchers, industry CEOs, and financial community leaders. The programme will feature focused panel discussions, up to 20 emerging company presentations, guest speakers, and survey data on attendees’ and ESCRS delegates’ interests, trends, and concerns. The programme includes live voting and commentary, as well as plenty of breaks for socializing and networking. A new session introduced in 2023—‘The Innovators Den’—returns, featuring new proposals developed directly by clinical ophthalmologists and presented before an all-star panel of eminent ophthalmologists and executives.
Tags: iNovation Day, ESCRS Annual Congress, Barcelona, The Innovators Den, meeting, ESCRS
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.